NasdaqCM:AGENBiotechs
Agenus (AGEN) Is Up 54.3% After Oversubscribed US$340 Million Private Placement To Fund ROBBIN Trial - Has The Bull Case Changed?
Agenus recently announced an oversubscribed private placement of up to US$340 million, including a US$85,000,000 Regulation D securities purchase agreement with institutional investors such as Commodore Capital, RA Capital Management, TCGX, Invus, and Ligand Pharmaceuticals, alongside board expansion to add two Commodore-designated directors.